Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty

EIDD-1931

Copy Product Info
🥰Excellent
Catalog No. T8498Cas No. 3258-02-4
Alias NHC, Beta-d-N4-hydroxycytidine

EIDD-1931 (Beta-d-N4-hydroxycytidine) is a ribonucleoside analog with antiviral activity that inhibits the replication of severe acute respiratory syndrome coronavirus [SARS-CoV] in Vero 76 cells, Middle East respiratory syndrome coronavirus [MERS-CoV] in Calu-3 2B4 cells, and SARS-CoV-2 in Vero cells (IC50s = 0.1, 0.15, and 0.3 μM, respectively).

EIDD-1931

EIDD-1931

Copy Product Info
🥰Excellent
Purity: 99.73%
Catalog No. T8498Alias NHC, Beta-d-N4-hydroxycytidineCas No. 3258-02-4
EIDD-1931 (Beta-d-N4-hydroxycytidine) is a ribonucleoside analog with antiviral activity that inhibits the replication of severe acute respiratory syndrome coronavirus [SARS-CoV] in Vero 76 cells, Middle East respiratory syndrome coronavirus [MERS-CoV] in Calu-3 2B4 cells, and SARS-CoV-2 in Vero cells (IC50s = 0.1, 0.15, and 0.3 μM, respectively).
Pack SizePriceUSA WarehouseGlobal WarehouseQuantity
1 mg$33In StockIn Stock
5 mg$76In StockIn Stock
10 mg$118In StockIn Stock
25 mg$198In StockIn Stock
50 mg$289In StockIn Stock
100 mg$413In StockIn Stock
500 mg$943In StockIn Stock
Add to Cart
Add to Quotation
In Stock Estimated shipping dateUSA Warehouse[1-2 days] Global Warehouse[5-7 days]
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.
Questions
TargetMol
View More

Batch Information

Select Batch
Purity:99.73%
Color:White
Contact us for more batch information

Resource Download

Product Introduction

EIDD-1931 AI Summary
EIDD-1931 exhibits significant antimalarial, antiviral, and cytotoxic activities. It demonstrates antimalarial efficacy against Plasmodium falciparum with an IC50 of 610.0 ug/mL, utilizing a fluorescence-based SYBR-green assay. The compound also shows antiviral activity against various coronaviruses including SARS-CoV-2, SARS-CoV, MERS-CoV, and HCoV-OC43 with EC50 values ranging from 24.0 nM to 1556.0 nM, and it is effective against influenza A viruses (H1N1 and H3N2), influenza B virus, and dengue virus 2, with EC50 values up to 2840.0 nM. It exhibits minimal cytotoxicity in Vero cells and various others with CC50 values >100,000.0 nM, indicating a favorable selective index for therapeutic applications. Furthermore, EIDD-1931 acts on human mARC1 and mARC2 enzymes with turnover rates of 354.7-354.8 nmol/mg.min and 142.1-184.2 nmol/mg.min, respectively. In CD1 mice, it shows moderate to high oral bioavailability (36.0%-56.0%) and a half-life ranging from 2.7 to 5.2 hours, with notable drug uptake in the liver at doses of 150 to 500 mg/kg..
Note: Summary generated by AI. Data source: ChEMBL
Bioactivity
Description
EIDD-1931 (Beta-d-N4-hydroxycytidine) is a ribonucleoside analog with antiviral activity that inhibits the replication of severe acute respiratory syndrome coronavirus [SARS-CoV] in Vero 76 cells, Middle East respiratory syndrome coronavirus [MERS-CoV] in Calu-3 2B4 cells, and SARS-CoV-2 in Vero cells (IC50s = 0.1, 0.15, and 0.3 μM, respectively).
SynonymsNHC, Beta-d-N4-hydroxycytidine
Chemical Properties
Molecular Weight259.22
FormulaC9H13N3O6
Cas No.3258-02-4
SmilesOC[C@H]1O[C@H]([C@H](O)[C@@H]1O)n1cc\c(=N/O)[nH]c1=O
Relative Density.1.93 g/cm3 (Predicted)
Storage & Solubility Information
StorageIn solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature.
Solubility Information
DMSO: 255 mg/mL (983.72 mM), Sonication is recommended.
In Vivo Formulation
10% DMSO+40% PEG300+5% Tween 80+45% Saline: 2 mg/mL (7.72 mM), Sonication is recommended.
Please add the solvents sequentially, clarifying the solution as much as possible before adding the next one. Dissolve by heating and/or sonication if necessary. Working solution is recommended to be prepared and used immediately. The formulation provided above is for reference purposes only. In vivo formulations may vary and should be modified based on specific experimental conditions.
Solution Preparation Table
DMSO
1mg5mg10mg50mg
1 mM3.8577 mL19.2886 mL38.5773 mL192.8864 mL
5 mM0.7715 mL3.8577 mL7.7155 mL38.5773 mL
10 mM0.3858 mL1.9289 mL3.8577 mL19.2886 mL
20 mM0.1929 mL0.9644 mL1.9289 mL9.6443 mL
50 mM0.0772 mL0.3858 mL0.7715 mL3.8577 mL
100 mM0.0386 mL0.1929 mL0.3858 mL1.9289 mL

Calculator

  • Molarity Calculator
  • Dilution Calculator
  • Reconstitution Calculator
  • Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the stock solution preparation method and in vivo formula preparation method:
TargetMol | Animal experiments For example, if the intended dosage is 10 mg/kg for animals weighing 20 g , with a dosing volume of 100 μL per animal, TargetMol | Animal experiments and a total of 10 animals are to be administered, using a formulation of TargetMol | reagent 10% DMSO+ 40% PEG300+ 5% Tween 80+ 45% Saline/PBS/ddH2O , the resulting working solution concentration would be 2 mg/mL.
Stock Solution Preparation:

Dissolve 2 mg of the compound in 100 μL DMSOTargetMol | reagent to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.

Preparation of the In Vivo Formulation:

1) Add 100 μL of the DMSOTargetMol | reagent stock solution to 400 μL PEG300TargetMol | reagent and mix thoroughly until the solution becomes clear.

2) Add 50 μL Tween 80 and mix well until fully clarified.

3) Add 450 μL Saline,PBS or ddH2OTargetMol | reagent and mix thoroughly until a homogeneous solution is obtained.

This example is provided solely to demonstrate the use of the In Vivo Formulation Calculator and does not constitute a recommended formulation for any specific compound. Please select an appropriate dissolution and formulation strategy based on your experimental model and route of administration.
All co-solvents required for this protocol, includingDMSO, PEG300/PEG400, Tween 80, SBE-β-CD, and Corn oil, are available for purchase on the TargetMol website.
1 Enter information below:
mg/kg
g
μL
2 Enter the in vivo formulation:
% DMSO
%
% Tween 80
% Saline/PBS/ddH2O

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc

Keywords

Related Tags: buy EIDD-1931 | purchase EIDD-1931 | EIDD-1931 cost | order EIDD-1931 | EIDD-1931 chemical structure | EIDD-1931 formula | EIDD-1931 molecular weight